2.In Vitro放射性医薬品の開発動向 : 測定方法の進歩と診断薬としての今後 : 1.核医学の今後はどう変化するか

概要

論文の詳細を見る
Radioimmunoassay, which was developed by Berson & Yalow, has been making excellent progress and advancement. It is becoming a simpler procedure with short time assay due to the switchover from the liquid-phase method to the solid-phase method and from the competitive assay to the sandwich assay. The progress in biotechnology made it possible to obtain highly purified antibodies having high specificity. The in vitro method of immunological diagnosis was developed in the endocrinological field at first, and then it came to be applied in the fields of cancer or infectious diseases. Now, it occupies a very important position as regards diagnostic medicine. The development of new diagnostic methods will make an important contribution to the progress of clinical medicine. A useful immunological method for screening test is expected and is being awaited in the field of cancer. In infectious disease and judgement of pregnancy, a new diagnostic method which can be used by anyone, at anytime, and in anywhere will open a big new market. Immunological diagnostic method will make great progress and advance by carving out new technology and a new field.
公益社団法人日本放射線技術学会の論文
1987-11-01